You can buy or sell SGEN and other stocks, options, ETFs, and crypto commission-free!
Seattle Genetics, Inc. Common Stock, also called Seattle Genetics, is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Read More Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.
52 Week High
52 Week Low
— per share
Expected Oct 29, After Hours